Clinical Trial Update: Clinical Trial on the Efficacy and Safety of Sirolimus-Eluting Stent (MiStent® System) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for a sirolimus-eluting stent (MiStent System) evaluating efficacy and safety in coronary heart disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Heart Disease

Drugs mentioned

• MiStent (Sirolimus-eluting stent)

Snippet

Sponsor: Micell Technologies | Conditions: Coronary Heart Disease | Phase 3 | Status: UNKNOWN